$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.60 | 400 | 7,040 | 158,784 | 159.2 K to 158.8 K (-0.25 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.61 | 100 | 1,761 | 159,184 | 159.3 K to 159.2 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.62 | 200 | 3,524 | 159,284 | 159.5 K to 159.3 K (-0.13 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.63 | 100 | 1,763 | 159,484 | 159.6 K to 159.5 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.64 | 175 | 3,087 | 159,584 | 159.8 K to 159.6 K (-0.11 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.65 | 25 | 441 | 159,659 | 159.7 K to 159.7 K (-0.02 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.66 | 100 | 1,766 | 159,684 | 159.8 K to 159.7 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.67 | 100 | 1,767 | 159,784 | 159.9 K to 159.8 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.68 | 100 | 1,768 | 159,884 | 160 K to 159.9 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.72 | 200 | 3,544 | 159,984 | 160.2 K to 160 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.73 | 200 | 3,546 | 160,184 | 160.4 K to 160.2 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.77 | 200 | 3,554 | 160,384 | 160.6 K to 160.4 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.81 | 200 | 3,562 | 160,584 | 160.8 K to 160.6 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.84 | 200 | 3,568 | 160,784 | 161 K to 160.8 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.89 | 200 | 3,578 | 160,984 | 161.2 K to 161 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.93 | 600 | 10,758 | 161,184 | 161.8 K to 161.2 K (-0.37 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.96 | 200 | 3,592 | 161,784 | 162 K to 161.8 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.97 | 100 | 1,797 | 161,984 | 162.1 K to 162 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.98 | 100 | 1,798 | 162,084 | 162.2 K to 162.1 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.01 | 200 | 3,602 | 162,184 | 162.4 K to 162.2 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.04 | 100 | 1,804 | 162,384 | 162.5 K to 162.4 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.05 | 100 | 1,805 | 162,484 | 162.6 K to 162.5 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.08 | 200 | 3,616 | 162,584 | 162.8 K to 162.6 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.12 | 200 | 3,624 | 162,784 | 163 K to 162.8 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.13 | 200 | 3,626 | 162,984 | 163.2 K to 163 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.15 | 100 | 1,815 | 163,184 | 163.3 K to 163.2 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.16 | 100 | 1,816 | 163,284 | 163.4 K to 163.3 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.17 | 100 | 1,817 | 163,384 | 163.5 K to 163.4 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.22 | 200 | 3,644 | 163,484 | 163.7 K to 163.5 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.23 | 100 | 1,823 | 163,684 | 163.8 K to 163.7 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.27 | 100 | 1,827 | 163,784 | 163.9 K to 163.8 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.31 | 500 | 9,155 | 163,884 | 164.4 K to 163.9 K (-0.30 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.41 | 200 | 3,682 | 164,384 | 164.6 K to 164.4 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.47 | 200 | 3,694 | 164,584 | 164.8 K to 164.6 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.50 | 100 | 1,850 | 164,784 | 164.9 K to 164.8 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.51 | 100 | 1,851 | 164,884 | 165 K to 164.9 K (-0.06 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.60 | 200 | 3,720 | 164,984 | 165.2 K to 165 K (-0.12 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 18.64 | 200 | 3,728 | 165,184 | 165.4 K to 165.2 K (-0.12 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | A | 19.81 | 34,000 | 673,540 | 34,000 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Grant | A | 0.00 | 13,600 | 0 | 36,901 | 23.3 K to 36.9 K (+58.37 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 19.81 | 37,500 | 742,875 | 37,500 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 15,000 | 0 | 28,589 | 13.6 K to 28.6 K (+110.38 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 19.81 | 31,000 | 614,110 | 31,000 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 12,400 | 0 | 16,416 | 4 K to 16.4 K (+308.76 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 19.81 | 62,500 | 1,238,125 | 62,500 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 165,384 | 140.4 K to 165.4 K (+17.81 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 21.50 | 83,000 | 1,784,500 | 495,846 | 578.8 K to 495.8 K (-14.34 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 22.85 | 17,000 | 388,484 | 578,846 | 595.8 K to 578.8 K (-2.85 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 1,923 | 5,000 | 0 | |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 2.60 | 2,564 | 6,666 | 0 | |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.23 | 787 | 18,282 | 23,301 | 24.1 K to 23.3 K (-3.27 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.24 | 200 | 4,648 | 24,088 | 24.3 K to 24.1 K (-0.82 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.30 | 1,000 | 23,300 | 24,288 | 25.3 K to 24.3 K (-3.95 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.35 | 700 | 16,345 | 25,288 | 26 K to 25.3 K (-2.69 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.46 | 400 | 9,384 | 25,988 | 26.4 K to 26 K (-1.52 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.47 | 100 | 2,347 | 26,388 | 26.5 K to 26.4 K (-0.38 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.50 | 800 | 18,800 | 26,488 | 27.3 K to 26.5 K (-2.93 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.51 | 500 | 11,755 | 27,288 | 27.8 K to 27.3 K (-1.80 %) |
Feb 19 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 2.60 | 4,487 | 11,666 | 27,788 | 23.3 K to 27.8 K (+19.26 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.90 | 410 | 9,389 | 13,589 | 14 K to 13.6 K (-2.93 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.91 | 15 | 344 | 13,999 | 14 K to 14 K (-0.11 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.00 | 1,283 | 29,509 | 14,014 | 15.3 K to 14 K (-8.39 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.03 | 17 | 392 | 15,297 | 15.3 K to 15.3 K (-0.11 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.04 | 500 | 11,520 | 15,314 | 15.8 K to 15.3 K (-3.16 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.07 | 200 | 4,614 | 15,814 | 16 K to 15.8 K (-1.25 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.30 | 325 | 7,248 | 16,014 | 16.3 K to 16 K (-1.99 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.31 | 175 | 3,904 | 16,339 | 16.5 K to 16.3 K (-1.06 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.35 | 225 | 5,029 | 16,514 | 16.7 K to 16.5 K (-1.34 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.36 | 200 | 4,472 | 16,739 | 16.9 K to 16.7 K (-1.18 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.37 | 400 | 8,948 | 16,939 | 17.3 K to 16.9 K (-2.31 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.46 | 300 | 6,738 | 17,339 | 17.6 K to 17.3 K (-1.70 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.50 | 400 | 9,400 | 17,639 | 18 K to 17.6 K (-2.22 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.64 | 400 | 9,456 | 18,039 | 18.4 K to 18 K (-2.17 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.31 | 300 | 6,693 | 4,016 | 4.3 K to 4 K (-6.95 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.36 | 207 | 4,629 | 4,316 | 4.5 K to 4.3 K (-4.58 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.40 | 200 | 4,480 | 4,523 | 4.7 K to 4.5 K (-4.23 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.51 | 100 | 2,351 | 4,723 | 4.8 K to 4.7 K (-2.07 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.52 | 100 | 2,352 | 4,823 | 4.9 K to 4.8 K (-2.03 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.64 | 200 | 4,728 | 4,923 | 5.1 K to 4.9 K (-3.90 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 22.85 | 350 | 7,998 | 27,788 | 28.1 K to 27.8 K (-1.24 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 22.90 | 700 | 16,030 | 28,138 | 28.8 K to 28.1 K (-2.43 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.00 | 1,086 | 24,978 | 28,838 | 29.9 K to 28.8 K (-3.63 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.01 | 400 | 9,204 | 29,924 | 30.3 K to 29.9 K (-1.32 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.15 | 700 | 16,205 | 30,324 | 31 K to 30.3 K (-2.26 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 23.34 | 350 | 8,169 | 31,024 | 31.4 K to 31 K (-1.12 %) |
Jan 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Ridgeback Capital Investments ... | 10% Owner | Sell | S | 25.68 | 700,000 | 17,976,000 | 2,628,762 | 3.3 M to 2.6 M (-21.03 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 3,286 | 8,544 | 14,890 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 2,564 | 6,666 | 0 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 1,150 | 2,990 | 0 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 25.00 | 7,000 | 175,000 | 5,123 | 12.1 K to 5.1 K (-57.74 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 3,286 | 8,544 | 12,123 | 8.8 K to 12.1 K (+37.18 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 2,564 | 6,666 | 8,837 | 6.3 K to 8.8 K (+40.87 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 1,150 | 2,990 | 6,273 | 5.1 K to 6.3 K (+22.45 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 132 | 343 | 1,150 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 1,282 | 3,333 | 0 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 5,586 | 14,524 | 0 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.00 | 2,758 | 63,434 | 5,123 | 7.9 K to 5.1 K (-35.00 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.01 | 925 | 21,284 | 7,881 | 8.8 K to 7.9 K (-10.50 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.02 | 1,400 | 32,228 | 8,806 | 10.2 K to 8.8 K (-13.72 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.03 | 400 | 9,212 | 10,206 | 10.6 K to 10.2 K (-3.77 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.10 | 17 | 393 | 10,606 | 10.6 K to 10.6 K (-0.16 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.20 | 500 | 11,600 | 10,623 | 11.1 K to 10.6 K (-4.50 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.23 | 1,000 | 23,230 | 11,123 | 12.1 K to 11.1 K (-8.25 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 132 | 343 | 12,123 | 12 K to 12.1 K (+1.10 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 1,282 | 3,333 | 11,991 | 10.7 K to 12 K (+11.97 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 5,586 | 14,524 | 10,709 | 5.1 K to 10.7 K (+109.04 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.50 | 1,112 | 22,796 | 18,439 | 19.6 K to 18.4 K (-5.69 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.51 | 88 | 1,805 | 19,551 | 19.6 K to 19.6 K (-0.45 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.60 | 400 | 8,240 | 19,639 | 20 K to 19.6 K (-2.00 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.62 | 825 | 17,012 | 20,039 | 20.9 K to 20 K (-3.95 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.50 | 600 | 12,300 | 5,123 | 5.7 K to 5.1 K (-10.48 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.55 | 200 | 4,110 | 5,723 | 5.9 K to 5.7 K (-3.38 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.60 | 200 | 4,120 | 5,923 | 6.1 K to 5.9 K (-3.27 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.62 | 107 | 2,206 | 6,123 | 6.2 K to 6.1 K (-1.72 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.22 | 200 | 4,044 | 6,230 | 6.4 K to 6.2 K (-3.11 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.27 | 200 | 4,054 | 6,430 | 6.6 K to 6.4 K (-3.02 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.29 | 200 | 4,058 | 6,630 | 6.8 K to 6.6 K (-2.93 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.32 | 200 | 4,064 | 6,830 | 7 K to 6.8 K (-2.84 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.38 | 200 | 4,076 | 7,030 | 7.2 K to 7 K (-2.77 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.39 | 200 | 4,078 | 7,230 | 7.4 K to 7.2 K (-2.69 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.50 | 200 | 4,100 | 7,430 | 7.6 K to 7.4 K (-2.62 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.56 | 200 | 4,112 | 7,630 | 7.8 K to 7.6 K (-2.55 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.66 | 200 | 4,132 | 7,830 | 8 K to 7.8 K (-2.49 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.21 | 216 | 4,365 | 31,374 | 31.6 K to 31.4 K (-0.68 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.26 | 100 | 2,026 | 31,590 | 31.7 K to 31.6 K (-0.32 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.28 | 300 | 6,084 | 31,690 | 32 K to 31.7 K (-0.94 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.29 | 100 | 2,029 | 31,990 | 32.1 K to 32 K (-0.31 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.30 | 800 | 16,240 | 32,090 | 32.9 K to 32.1 K (-2.43 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.32 | 84 | 1,707 | 32,890 | 33 K to 32.9 K (-0.25 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.37 | 100 | 2,037 | 32,974 | 33.1 K to 33 K (-0.30 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.38 | 300 | 6,114 | 33,074 | 33.4 K to 33.1 K (-0.90 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.39 | 600 | 12,234 | 33,374 | 34 K to 33.4 K (-1.77 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.53 | 900 | 18,477 | 33,974 | 34.9 K to 34 K (-2.58 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.59 | 400 | 8,236 | 34,874 | 35.3 K to 34.9 K (-1.13 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.60 | 100 | 2,060 | 35,274 | 35.4 K to 35.3 K (-0.28 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.22 | 500 | 10,110 | 140,384 | 140.9 K to 140.4 K (-0.35 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.26 | 100 | 2,026 | 140,884 | 141 K to 140.9 K (-0.07 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.28 | 700 | 14,196 | 140,984 | 141.7 K to 141 K (-0.49 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.29 | 700 | 14,203 | 141,684 | 142.4 K to 141.7 K (-0.49 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.30 | 848 | 17,214 | 142,384 | 143.2 K to 142.4 K (-0.59 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.31 | 562 | 11,414 | 143,232 | 143.8 K to 143.2 K (-0.39 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.36 | 51 | 1,038 | 143,794 | 143.8 K to 143.8 K (-0.04 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.37 | 700 | 14,259 | 143,845 | 144.5 K to 143.8 K (-0.48 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.39 | 751 | 15,313 | 144,545 | 145.3 K to 144.5 K (-0.52 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.42 | 499 | 10,190 | 145,296 | 145.8 K to 145.3 K (-0.34 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.43 | 88 | 1,798 | 145,795 | 145.9 K to 145.8 K (-0.06 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.48 | 500 | 10,240 | 145,883 | 146.4 K to 145.9 K (-0.34 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.51 | 100 | 2,051 | 146,383 | 146.5 K to 146.4 K (-0.07 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.52 | 201 | 4,125 | 146,483 | 146.7 K to 146.5 K (-0.14 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.53 | 100 | 2,053 | 146,684 | 146.8 K to 146.7 K (-0.07 %) |